I admire Adam Finkel for his intellectual acumen and force. Adam has been
fighting the good fight relative to exposure limits since I have known
him. My friend and colleague Tom
Armstrong, recently made me aware
of items that Adam and his colleagues at the Center for Public Integreity in Washington, DC have published online that provide a remarkably
user-friendly and informative tool
that shows the predicted level of protection provided by OSHA occupational exposure limits (OELs) versus those provided by the American Conference of Governmental Industrial
Hygienist (ACGIH).
One can always argue with how the quantitative level of risks
were determined. Adam and his
colleagues anticipated this and provide the details and the rationale
online: http://www.publicintegrity.org/2015/06/26/17563/about-our-methodology
For me perhaps the most interesting and useful tool they published in this
recent effort is their “Unequal Risk
Investigation” cancer-risk graphic. A screen
shot of this tool is below:
you will be treated to the live version of this tool that allows one to see the
difference for OSHA and ACGIH exposure limits for carcinogens on a scale for an
estimated 1 in 1000 (10-3) to 1000 in 1000 (10-0) risk of cancer from exposure at the exposure
limits. You can filter the information
by any of 12 categories including construction, manufacturing, health care and
agriculture. The tool also allows you to
drill down to the individual chemical for specific risk estimates. In the above screenshot the details of the estimated risks and uses of trichloroethylene are shown.
For those of you who read this blog regularly, you may recognize
that what Adam and his colleagues are doing here is pretty much in line with the idea of Risk@OEL
in which the residual risk at any exposure limit is presented as part of the
documentation of that limit. Because of our inability to reasonably
establish true thresholds of risk from exposure to non-carcinogens, my thinking
is that residual risk should be calculated (with error bands) for all toxic
end-points not just cancer.
Indeed, I believe it is important that we all need to be aware of the significant uncertainty that
exists around these estimates. However,
uncertainty notwithstanding, my sense is that we need to openly provide these
estimates along with our best understanding of the error bands associated with
them.
I would love to hear your comments about the information and
ideas being presented here. Do you believe it is OK not to include these estimates and their uncertainties in the documentation of the exposure limits?
No comments:
Post a Comment